Accenture has acquired two companies, Alfahealth and Industries eXcellence Group (IndX), to strengthen its healthcare and manufacturing technology capabilities. Alfahealth will expand Accenture's healthcare practice in Italy with a digital health platform, adding about 1,200 professionals. IndX specializes in Siemens software and will enhance Accenture's Siemens Business Group, focusing on modernizing product development and supply chains using AI and digital technologies. These moves come ahead of Accenture's earnings report scheduled for June 18, 2026, with analysts showing mixed price targets but generally positive ratings.
Accenture plc reported strong quarterly results, prompting a valuation increase and signaling the start of a recovery with over 20% total return recently. Management projects 3–6% revenue growth, a 15.9–16.1% operating margin, and plans $5 billion in...
Accenture plc received a Hold rating due to its current valuation already reflecting a 3% organic growth forecast and unresolved risks related to AI. Despite strong Q4 managed services bookings and stable demand, the company faces ongoing pricing pre...
Accenture's stock was downgraded from buy to hold following a 70% rise in its share price and disappointing growth metrics. In Q4, revenue grew 6% year-over-year, but only 3% was organic growth, which is below inflation. The company's fiscal 2027 gui...
Accenture's stock fell nearly 60% from its peak amid fears that AI would reduce its consulting revenue, but it surged nearly 16% after a strong earnings report. Analyst Kevin McVeigh from UBS maintains a $275 price target, seeing 30% upside due to Ac...
On October 1, 2026, Nexalin Technology surged 76.4% after securing a 10-year exclusive deal for its medical device in South America. Armada Acquisition Corp. II jumped 42.9% following shareholder approval of its merger with Evernorth, expected to clo...
